Methods for (a) preventing hypoxic damage to a potentially transplantable organ or tissue prior to explanation of that organ or tissue from the body of a mammalian transplant donor and (b) preventing rejection of a transplanted organ or tissue in a human or veterinary transplant recipient. The methods comprise placing a heat exchange apparatus in the vasculature of the donor or recipient and using that heat exchange apparatus to cool at least a portion of the body of the donor or recipient to a temperature below normothermia (e.g. below normothermia and sometimes between about 30° C. and about 36° C.).
|
0. 36. A method for deterring rejection of a transplanted organ or tissue in a body of a mammalian transplant recipient, said method comprising the steps of:
a. placing an intravascular heat exchange apparatus within a blood vessel of the recipient such that the recipient's blood continues to circulate through that blood vessel and heat is exchanged between the circulating blood and the intravascular heat exchange apparatus; and,
b. using the intravascular heat exchange apparatus to cool the recipient's flowing blood, thereby lowering the recipient's core body temperature to a temperature that is below normothermia.
0. 1. A method for preventing hypoxic damage to a potentially transplantable organ or tissue prior to explantation of the organ or tissue from the body of a mammalian donor; said method comprising the steps of:
a. placing an intravascular heat exchange apparatus within a blood vessel of the donor such that the donor's blood continues to circulate through that blood vessel and heat is exchanged between the circulating blood and the intravascular heat exchange apparatus; and,
b. using the intravascular heat exchange apparatus to cool the donor's flowing blood, thereby lowering the donor's core body temperature to a temperature that is below normothermia.
0. 2. A method according to
0. 3. A method according to
0. 4. A method according to
0. 5. A method according to
0. 6. A method according to
0. 7. A method according to
0. 8. A method according to
0. 9. A method according to
0. 10. A method according to
0. 11. A method according to
0. 12. A method according to
0. 13. A method according to
0. 14. A method according to
0. 15. A method according to
0. 16. A method according to
0. 17. A method according to
heart;
lung;
liver;
kidney;
nervous tissue;
tendon;
bone;
a limb;
a finger;
a toe;
skin;
cornea;
bone marrow; and,
intestine.
0. 18. A method according to
monitoring the temperature of at least a portion of the donor's body and adjusting the heat exchange between the heat exchanger and the donor's blood to maintain the monitored temperature within a desired range.
0. 19. A method according to
0. 20. A method according to
0. 21. A method according to
0. 22. A method according to
0. 23. A method according to
0. 24. A method according to
0. 25. A method according to
0. 26. A method according to
0. 27. A method according to
0. 28. A method according to
0. 29. A method according to
0. 30. A method according to
0. 31. A method according to
0. 32. A method as in
0. 33. A method as in
0. 34. A method according to
kidney;
lung;
liver;
nervous tissue;
tendon;
bone;
a limb;
a finger;
a toe;
skin;
cornea;
bone marrow; and,
intestine.
0. 35. A method according to
0. 37. A method according to claim 36 wherein Step a comprises inserting a heat exchange catheter having a heat exchange region into the vasculature of the recipient and positioning the catheter such that blood flowing to at least the transplanted organ or tissue passes within heat exchange proximity to the heat exchange region and wherein Step b comprises exchanging heat with the blood that passes in heat exchange proximity to the heat exchange region for a period of time sufficient to cool at least the transplanted organ or tissue to a temperature below normothermia.
0. 38. A method as in claim 37 further comprising the steps of inserting a second heat exchange catheter in heat exchange proximity to the blood flowing away from the transplanted organ or tissue to maintain at least a portion of the recipient's body other than the translanted organ or tissue at a temperature different than the organ or tissue.
0. 39. A method according to claim 36 wherein the temperature is between approximately 30° C. and approximately 36° C.
0. 40. A method according to claim 36 wherein the intravascular heat exchange apparatus is an elongate flexible catheter having a heat exchange region formed on a portion of the catheter that becomes inserted into the recipient's vasculature.
0. 41. A method according to claim 40 wherein the heat exchange region of the catheter occupies less than the full length of the catheter portion that becomes inserted in the recipient's vasculature.
0. 42. A method according to claim 36 wherein the heat exchange apparatus is placed in the recipient's venous vasculature.
0. 43. A method according to claim 42 wherein the heat exchange apparatus is placed in the recipient's vena cava.
0. 44. A method according to claim 43 wherein the heat exchange apparatus is placed in the recipient's inferior vena cava.
0. 45. A method according to claim 44 wherein the heat exchange apparatus is placed in the recipient's superior vena cava.
0. 46. A method according to claim 36 wherein the recipient's entire body is cooled to a temperature below normothermia.
0. 47. A method according to claim 36 wherein the core body temperature is cooled to a desired temperature below normothermia and the remainder of the recipient's body is either hypothermic, normothermic or hyperthermic.
0. 48. A method according to claim 36 wherein at least one raised area is formed on the heat exchange apparatus to increase its heat exchange surface area.
0. 49. A method according to claim 36 wherein the organ or tissue is selected from the group consisting of:
heart;
lung;
liver;
kidney;
nervous tissue;
tendon;
bone;
a limb;
a finger;
a toe;
skin;
cornea;
bone marrow; and,
intestine.
0. 50. A method according to claim 36 further comprising the steps of:
monitoring the temperature of at least a portion of the recipient's body and adjusting the heat exchange between the heat exchanger and the recipient's blood to maintain the monitored temperature within a desired range.
0. 51. A method according to claim 36 wherein the heat exchange device comprises a heat exchanger through which heat exchange fluid is circulated.
0. 52. A method according to claim 36 wherein said heat exchanger comprises a heat exchange balloon.
0. 53. A method according to claim 36 wherein the heat exchange apparatus comprises a balloon catheter, the balloon catheter comprising a catheter shaft and a balloon located on the catheter shaft, the balloon functioning as a heat exchanger, said balloon having an interior space and an exterior surface, the exterior surface of the balloon being in heat exchange proximity to blood that flows past it, the shaft having an inflow lumen and an outflow lumen wherein the inflow lumen is in fluid communication with the interior space of said balloon and the outflow lumen is in fluid communication with the interior space of said balloon, and wherein heat exchange fluid is circulated into the balloon through the inflow lumen and out of the balloon through the outflow lumen.
0. 54. A method according to claim 36 comprising the additional step of sensing the temperature of the recipient, and adjusting the step of exchanging heat with the blood in response to the sensed temperature.
0. 55. A method according to claim 54 wherein the temperature sensed is the temperature of the recipient's blood at a location that is not within heat exchange proximity to the intravascular heat exchange apparatus.
0. 56. A method according to claim 54 wherein the temperature sensed is the recipient's body temperature as measured at the recipient's tympanic membrane.
0. 57. A method according to claim 54 wherein the temperature sensed is the recipient's rectal temperature.
0. 58. A method according to claim 54 wherein the temperature sensed is representative of the whole body temperature of the recipient.
0. 59. A method according to claim 54 comprising the additional steps of selecting a target temperature below normothermia and maintaining the temperature of at least the tissue or organ at the target temperature after said target temperature has been reached.
0. 60. A method according to claim 59 comprising the additional steps of adding heat when the sensed temperature is below the target temperature, and removing heat from the blood when the sensed temperature is above the target temperature.
0. 61. A method according to claim 36 wherein Step a comprises inserting a heat exchange catheter having a heat exchange region into the vasculature of a recipient and positioning the catheter such that it exchanges heat with blood flowing to the organ or tissue to maintain the temperature of the organ or tissue at about the temperature at which significant anti-platelet activity is effected.
|
The ribbon configuration of
The deflated profile of the heat exchange region is small enough to make an advantageous insertion profile, as small as 7 French for some applications. Even with this low insertion profile, the heat exchange region is efficient enough to adequately exchange heat with blood flowing past the heat exchange region to alter the temperature of the blood sufficient for anti-platelet action and affect the temperature of tissue downstream of the heat exchange region. Because of its smaller profile, it is possible to affect the temperature of blood in smaller vessels and thereby provide treatment to more localized body areas.
This configuration has a further advantage when the heat exchange region is placed in a tubular conduit such as a blood vessel, especially where the diameter of the vessel is approximately that of the major axis (width) of the cross section of the heat exchange region. The configuration tends to cause the heat exchange region to center itself in the middle of the vessel. This creates two roughly semicircular flow channels within the vessel, with the blood flow channels divided by the relatively flat ribbon configuration of the heat exchange region. It has been found that the means for providing maximum surface for heat exchange while creating minimum restriction to flow is this configuration, a relatively flat heat exchange surface that retains two approximately equal semi-circular cross-sections. This can be seen in reference to
In the example of
Additionally, even after the declaration or pronouncement of brain death has been made, there may be substantial further delays before the organs or tissues can be harvested from the donor's body. This is especially true in cases where a time-critical organ such as the heart has been matched to a recipient who is located far away from the donor and it is necessary to wait until a surgical team has been flown in from the recipient's location to perform the organ harvest and to then transport the critical organ to the location where the transplant surgery is to be conducted. Accordingly, in such cases, the provision of endovascular hypothermia even after the brain death declaration or pronouncement has been made may be beneficial in avoiding hypoxic damage to donor's the organs or tissues.
Moreover, a substantial period of time may be required before the brain death declaration or pronouncement may be made, as it is often necessary for heath care workers to locate and obtain written consent from the donor's family and to perform extensive tests and evaluations to confirm that the donor is in fact brain dead. The exact criteria by which brain death may be declared or pronounced may differ from state to state, country to country, or even institution to institution. In many jurisdictions, a declaration or pronouncement of brain death can only be made after numerous tests and evaluations have been completed (collectively referred to herein as the “brain death work-up”). These required tests and evaluations may include a clinical assessment to establish the lack of neurological responses and reflexes, hypoxia test(s) to confirm that the spontaneous respiratory drive is absent, and multiple electroencephalograms (EEGs) taken at time points separated by a prescribed waiting period (e.g., 24 hours). In at least some institutions, the declaration or pronouncement of brain death must be made by no fewer than two (2) physicians. Thus, the time period required to obtain the requisite consent and complete the entire brain death work up may span 48 hours or even longer. The provision of endovascular hypothermia during the brain death work up period in accordance with the method of
Specifically referring to the method of
In cases where it is desired to minimize or prevent cooling of portions of the body other than the selected body portion (e.g., a limb, organ or group of organs), a second heat exchange apparatus may be placed in one or more other blood vessels from which blood flows out of or away from the selected body portion (e.g., a limb, organ or group of organs) and the second heat exchange apparatus may be used to rewarm blood that flows out of or away from the selected body portion (e.g., a limb, organ or group of organs or blood flowing from the heart), thereby preventing the remainder of the body or at least the heart from becoming as hypothermic as the tissue or organ desired for transplantation. In this manner it is possible to cool the organ or tissue for transplantation well below the 25° C. temperature at which the heart begins to experience fibrillation or other adverse events, and yet keep the heart above that temperature to maintain effective cardiac function. For example, a first, cooling catheter might be placed in the renal artery to cool a kidney and a second warming catheter be placed in the renal vein or the IVC to warm blood returning from the kidneys to the heart. In fact, several additional catheters might be used, for example a cooling catheter might be placed in the artery for each kidney, and a warming catheter in each of the veins coming from the kidneys, and a warming catheter in IVC all to keep the heart warm enough to function effectively as a pump, and yet cool the target organ or tissue. This method of persevering organs or tissue is illustrated in the flow chart of
Although several illustrative examples of means for practicing the invention are described above, these examples are by no means exhaustive of all possible means for practicing the invention. The scope of the invention should therefore be determined with reference to the appended claims, along with the full range of equivalents to which those clams are entitled.
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
4723939, | Jul 31 1986 | The Research Foundation of State Univ. of New York | Apparatus and method for multiple organ procurement |
5149321, | Oct 10 1990 | ORGAN RECOVERY SYSTEMS, INC | Brain resuscitation device and method for performing the same |
5234405, | Oct 10 1990 | ORGAN RECOVERY SYSTEMS, INC | Brain resuscitation device and method for performing the same |
5395314, | Oct 10 1990 | ORGAN RECOVERY SYSTEMS, INC | Brain resuscitation and organ preservation device and method for performing the same |
5486208, | Feb 10 1993 | ZOLL CIRCULATION, INC | Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification |
5574019, | Apr 19 1991 | LINEAGE CELL THERAPEUTICS, INC | Method of perfusing a primate |
5584804, | Oct 10 1990 | ORGAN RECOVERY SYSTEMS, INC | Brain resuscitation and organ preservation device and method for performing the same |
5701746, | Jul 12 1994 | Electrolux S.A.R.L. | Method to refrigerate a jacket for keeping a transplant cold |
5709654, | Oct 10 1990 | ORGAN RECOVERY SYSTEMS, INC | Apparatus for cooling living tissue |
5752929, | Oct 10 1990 | ORGAN RECOVERY SYSTEMS, INC | Method of preserving organs other than the brain |
5827222, | Oct 10 1990 | ORGAN RECOVERY SYSTEMS, INC | Method of treating at least one of brain and associated nervous tissue injury |
5837003, | Feb 10 1993 | ZOLL CIRCULATION, INC | Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification |
5957963, | Jan 23 1998 | ZOLL CIRCULATION, INC | Selective organ hypothermia method and apparatus |
6030412, | May 22 1991 | LIFE SCIENCE HOLDINGS, INC | Apparatus and method for cooling the brain, brain stem and associated neurologic tissues |
6080538, | Jun 04 1993 | BioTime, Inc. | Plasma like solution and methods of use |
6096068, | Jan 23 1998 | ZOLL CIRCULATION, INC | Selective organ cooling catheter and method of using the same |
6110168, | Feb 10 1993 | ZOLL CIRCULATION, INC | Method and apparatus for controlling a patient's body temperature by in situ blood temperature modifications |
6126684, | Apr 21 1998 | ZOLL CIRCULATION, INC | Indwelling heat exchange catheter and method of using same |
6146411, | Dec 24 1998 | ZOLL CIRCULATION, INC | Cooling system for indwelling heat exchange catheter |
6149670, | Mar 11 1999 | ZOLL CIRCULATION, INC | Method and system for treating cardiac arrest using hypothermia |
6149673, | Feb 10 1993 | ZOLL CIRCULATION, INC | Method for controlling a patient's body temperature by in situ blood temperature modification |
6149676, | Feb 10 1993 | ZOLL CIRCULATION, INC | Catheter system for controlling a patient's body temperature by in situ blood temperature modification |
6224624, | Mar 24 1998 | ZOLL CIRCULATION, INC | Selective organ cooling apparatus and method |
6231594, | Aug 11 1999 | ZOLL CIRCULATION, INC | Method of controlling body temperature while reducing shivering |
6264679, | Aug 20 1999 | ZOLL CIRCULATION, INC | Heat exchange catheter with discrete heat exchange elements |
6410218, | Jun 04 1993 | LINEAGE CELL THERAPEUTICS, INC | Plasma-like solution |
6413233, | Aug 18 1995 | FIRST CIRCLE MEDICAL, INC | Perfusion hyperthermia treatment system and method |
6444418, | Jun 04 1993 | LINEAGE CELL THERAPEUTICS, INC | Plasma-like solution |
6497721, | Feb 10 1993 | ZOLL CIRCULATION, INC | Method and apparatus for regional and whole body temperature modification |
6620188, | Aug 24 1998 | ZOLL CIRCULATION, INC | Methods and apparatus for regional and whole body temperature modification |
6736836, | Feb 17 2000 | Johns Hopkins University | Transplant organ external cooling system |
WO10494, | |||
WO1043661, | |||
WO9511055, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Sep 06 2007 | HORIZON TECHNOLOGY FUNDING COMPANY LLC | BAY CITY CAPITAL FUND IV, L P | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 019781 | /0792 | |
Sep 07 2007 | RADIANT MEDICAL, INC | BAY CITY CAPITAL FUND IV L P | SECURITY AGREEMENT | 019812 | /0192 | |
Sep 18 2007 | RADIANT MEDICAL, INC | ZOLL CIRCULATION, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020684 | /0535 | |
Sep 18 2007 | BAY CITY CAPITAL FUND IV, L P | ZOLL CIRCULATION, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020684 | /0535 | |
Dec 08 2009 | ZOLL Circulation, Inc. | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |
Feb 06 2021 | 4 years fee payment window open |
Aug 06 2021 | 6 months grace period start (w surcharge) |
Feb 06 2022 | patent expiry (for year 4) |
Feb 06 2024 | 2 years to revive unintentionally abandoned end. (for year 4) |
Feb 06 2025 | 8 years fee payment window open |
Aug 06 2025 | 6 months grace period start (w surcharge) |
Feb 06 2026 | patent expiry (for year 8) |
Feb 06 2028 | 2 years to revive unintentionally abandoned end. (for year 8) |
Feb 06 2029 | 12 years fee payment window open |
Aug 06 2029 | 6 months grace period start (w surcharge) |
Feb 06 2030 | patent expiry (for year 12) |
Feb 06 2032 | 2 years to revive unintentionally abandoned end. (for year 12) |